Skip to content

Fronto-Parietal Transcranial Alternating Current Stimulation for ADHD in Children and Adolescents

Effects and Neural Mechanisms of Fronto-Parietal Transcranial Alternating Current Stimulation in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07633275
Enrollment
38
Registered
2026-06-08
Start date
2026-03-26
Completion date
2026-06-29
Last updated
2026-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attention-Deficit/Hyperactivity Disorder

Brief summary

Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental condition in children and adolescents and is often associated with difficulties in attention, inhibitory control, working memory, and other executive functions. The fronto-parietal brain network is thought to play an important role in these cognitive functions. Transcranial alternating current stimulation (tACS) is a non-invasive brain stimulation technique that may influence brain activity. This study aims to evaluate whether 5-Hz tACS targeting the right frontal and parietal regions can improve executive functioning in children and adolescents aged 6 to 18 years with ADHD. The study also aims to explore whether any effects of tACS are related to changes in brain activity measured by electroencephalography (EEG). Participants will receive both active tACS and sham stimulation in a randomized, double-blind, crossover design. Clinical symptoms, executive function performance, and EEG measures will be assessed before and after each stimulation session. The main hypothesis is that active fronto-parietal tACS will produce greater improvement in executive functioning than sham stimulation, and that these effects may be associated with changes in EEG-measured brain activity.

Interventions

Active transcranial alternating current stimulation (tACS) will be delivered over the right frontoparietal region using a multi-electrode montage. Electrodes will be placed at F4, F2, AF4, and F6 over the right frontal region, and at P4, CP4, P6, and PO4 over the right parietal region. F4 and P4 will be configured as return electrodes according to the stimulation protocol. The stimulation will be applied as a 5-Hz sinusoidal alternating current with a total current intensity of 2 mA. Each stimulation session will last 12 minutes, including 60-second ramp-up and 60-second ramp-down periods.

Sham transcranial alternating current stimulation will use the same electrode montage, device appearance, and setup procedures as active tACS. Electrodes will be placed at F4, F2, AF4, and F6 over the right frontal region, and at P4, CP4, P6, and PO4 over the right parietal region. F4 and P4 will be configured as return electrodes as in the active stimulation condition. The sham procedure will include brief ramp-up and ramp-down periods of approximately 60 seconds to mimic the sensory experience of active stimulation, with no sustained current delivered.

Sponsors

Central South University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Intervention model description

This is a randomized, double-blind, sham-controlled crossover study. Participants will be randomly assigned in a 1:1 ratio to one of two intervention sequences. One sequence will receive active 5-Hz fronto-parietal transcranial alternating current stimulation (tACS) first, followed by sham stimulation. The other sequence will receive sham stimulation first, followed by active tACS. Each participant will receive both interventions, with a washout period of at least 2 days between sessions.

Eligibility

Sex/Gender
ALL
Age
6 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

1. Aged 6-18 years, Han Chinese, and right-handed; 2. Normal or corrected-to-normal vision and normal hearing; 3. Meets the DSM-5 diagnostic criteria for attention-deficit/hyperactivity disorder, predominantly inattentive presentation; 4. Meets the diagnostic threshold for inattention based on the parent-rated SNAP-IV scale; 5. Performance on the symbol cancellation test, converted to a grade-standardized score, is below the average level; 6. Has normal intelligence as confirmed by a brief intelligence assessment, with no significant emotional disorder or severe physical illness; 7. Able to cooperate with electroencephalography recording and transcranial alternating current stimulation.

Exclusion criteria

1. Meets diagnostic criteria for other major psychiatric disorders, such as schizophrenia or bipolar disorder; 2. Has severe physical diseases, such as significant intracranial lesions, thyroid disease, epilepsy, congenital heart disease, severe hematological disease, systemic lupus erythematosus, or significant visual or hearing impairment; 3. Has known obvious brain structural abnormalities based on available cranial imaging or medical history; 4. Has severe neurological disease, a clear family history of hereditary neurological disorders, or other conditions associated with high neurological risk; 5. Has metal implants or a cardiac pacemaker in the body, or has skull defects, holes, or fractures; 6. Is currently receiving other pharmacological or behavioral treatment for ADHD, such as methylphenidate medication or behavioral intervention.

Design outcomes

Primary

MeasureTime frameDescription
Change in attention performance measured by the Test of Attentional Performance for ChildrenBefore the first stimulation session, immediately after the first stimulation session, before the second stimulation session after a washout interval of at least 2 days, and immediately after the second stimulation session.Attention performance will be assessed using the Test of Attentional Performance for Children, including seven child-adapted attention subtests covering alertness, distractibility, divided attention, cognitive flexibility, response inhibition, sustained attention, and visual scanning. Outcome indices include reaction time, reaction time variability, accuracy, omission errors, commission errors, and other task-specific performance measures. In general, shorter reaction time, lower reaction time variability, higher accuracy, and fewer errors indicate better attention performance.
Change in task-related EEG indices during the visual search taskBefore the first stimulation session, immediately after the first stimulation session, before the second stimulation session after a washout interval of at least 2 days, and immediately after the second stimulation session.Task-related electroencephalography will be recorded during a visual search task in which participants identify the direction of a visual target and respond using a joystick. EEG outcomes will include event-related potential measures, such as N2pc amplitude and latency, time-frequency measures across predefined frequency bands, and alpha-band channel tuning function indices reflecting spatially selective neural responses. These measures do not have a fixed clinical score range.

Secondary

MeasureTime frameDescription
Change in ADHD symptoms measured by the SNAP-IV Parent Rating ScaleBefore the first stimulation session, immediately after the first stimulation session, before the second stimulation session after a washout interval of at least 2 days, and immediately after the second stimulation session.ADHD symptoms will be assessed using the parent-rated Swanson, Nolan, and Pelham-IV Rating Scale 26-item version (SNAP-IV). The scale includes items assessing inattention, hyperactivity/impulsivity, and oppositional symptoms. Each item is rated on a 4-point scale: 0 = not at all, 1 = just a little, 2 = quite a bit, and 3 = very much. Total score and subscale scores are calculated by summing or averaging the relevant items. Higher scores indicate more severe ADHD-related and oppositional symptoms.
Change in abnormal behaviors measured by the Aberrant Behavior Checklist-Second EditionBefore the first stimulation session, immediately after the first stimulation session, before the second stimulation session after a washout interval of at least 2 days, and immediately after the second stimulation session.Behavioral abnormalities will be assessed using the Aberrant Behavior Checklist-Second Edition (ABC-II). The ABC-II evaluates the frequency and severity of behavioral problems. Each item is rated on a 4-point scale: 0 = not a problem, 1 = the behavior is a problem but slight in degree, 2 = the problem is moderately serious, and 3 = the problem is severe. The total score is calculated by summing all item scores. Higher scores indicate more severe and widespread behavioral problems.
Change in depressive symptoms measured by the Patient Health Questionnaire-9Before the first stimulation session, immediately after the first stimulation session, before the second stimulation session after a washout interval of at least 2 days, and immediately after the second stimulation session.Depressive symptoms will be assessed using the Patient Health Questionnaire-9 (PHQ-9). The PHQ-9 includes 9 items assessing depressive symptoms during the past two weeks. Each item is rated on a 4-point scale: 0 = not at all, 1 = several days, 2 = more than half the days, and 3 = nearly every day. The total score ranges from 0 to 27, with higher scores indicating more severe depressive symptoms.
Change in anxiety symptoms measured by the Generalized Anxiety Disorder-7 scaleBefore the first stimulation session, immediately after the first stimulation session, before the second stimulation session after a washout interval of at least 2 days, and immediately after the second stimulation session.Anxiety symptoms will be assessed using the Generalized Anxiety Disorder-7 scale (GAD-7). The GAD-7 includes 7 items assessing the frequency of anxiety-related symptoms during the past two weeks. Each item is rated on a 4-point scale: 0 = not at all, 1 = several days, 2 = more than half the days, and 3 = nearly every day. The total score ranges from 0 to 21, with higher scores indicating more severe anxiety symptoms.
Change in sleep problems measured by the Sleep Disturbance Scale for ChildrenBefore the first stimulation session, immediately after the first stimulation session, before the second stimulation session after a washout interval of at least 2 days, and immediately after the second stimulation session.Sleep problems will be assessed using the Sleep Disturbance Scale for Children (SDSC). The SDSC is a parent-rated questionnaire assessing sleep-related problems in children and adolescents. Items are rated according to the frequency or severity of sleep disturbances on a 5-point scale. The total score is calculated by summing item scores. Higher scores indicate more severe sleep disturbances.
Change in sensory processing symptoms measured by the Short Sensory ProfileBefore the first stimulation session, immediately after the first stimulation session, before the second stimulation session after a washout interval of at least 2 days, and immediately after the second stimulation session.Sensory processing symptoms will be assessed using the Short Sensory Profile (SSP). The SSP is a parent-rated questionnaire assessing sensory processing patterns and sensory-related behavioral responses in children. Each item is rated on a 5-point scale according to how frequently the child shows a specific sensory response. The total score is calculated by summing item scores. Lower scores generally indicate greater sensory processing difficulties, whereas higher scores indicate fewer sensory processing difficulties.
Change in selective attention performance during the joystick-based visual search taskBefore the first stimulation session, immediately after the first stimulation session, before the second stimulation session after a washout interval of at least 2 days, and immediately after the second stimulation session.Selective attention performance will be assessed using a joystick-based visual search task. Participants will be asked to identify the direction or location of a visual target and respond using a joystick. Behavioral outcome indices will include predefined task performance measures, such as reaction time, movement time, response accuracy, response variability, omission errors, commission errors, and other task-specific joystick response measures. In general, shorter reaction time and movement time, lower response variability, higher accuracy, and fewer errors indicate better selective attention performance.
Change in resting-state EEG spectral parametersBefore the first stimulation session, immediately after the first stimulation session, before the second stimulation session after a washout interval of at least 2 days, and immediately after the second stimulation session.Resting-state electroencephalography will be recorded to assess spontaneous neural activity. EEG spectral outcomes will include power measures across predefined frequency bands and parameterized spectral measures derived from the power spectrum, such as aperiodic offset, aperiodic exponent, and periodic oscillatory components. These measures do not have a fixed clinical score range.

Countries

China

Contacts

PRINCIPAL_INVESTIGATORJianjun Ou

Central South University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 2, 2026